Verification of effective Zika virus reduction by production steps used in the manufacture of plasma-derived medicinal products

Transfusion. 2017 Mar;57(3):720-721. doi: 10.1111/trf.14038.

Authors

Nathan J Roth^{1

2}, Wolfram Schäfer^{1

3}, Birgit Popp^{1

3}, Martin Stucki^{1

2}, Randel Fang^{1

4}

Affiliations

¹ Global Pathogen Safety, CSL Behring, King of Prussia, PA.
² CSL Behring AG, Bern, Switzerland.
³ CSL Behring GmbH, Marburg, Germany.
⁴ CSL Behring (Australia) Pty Ltd, Broadmeadows, Australia.

PMID: 28297081
DOI: 10.1111/trf.14038

No abstract available

Publication types

Letter
Comment

MeSH terms

Commerce
Plasma*
Zika Virus Infection
Zika Virus*